Online citations, reference lists, and bibliographies.

Cyclodextrin Complexes: Perspective From Drug Delivery And Formulation

Shery Jacob, Anroop B Nair
Published 2018 · Biology, Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
Cyclodextrins (CDs) have been widely investigated as a unique pharmaceutical excipient for past few decades and is still explored for new applications. They are highly versatile oligosaccharides which possess multifunctional characteristics, and are mainly used to improve the physicochemical stability, solubility, dissolution rate, and bioavailability of drugs. Stability constant, factors affecting complexation, techniques to enhance complexation efficiency, the preparation methods for molecular inclusion complexes and release of guest molecules are discussed in brief. In addition, different CD derivatives and their pharmacokinetics are elaborated. Further, the significance of CD complex in aqueous solubility, dissolution and bioavailability, stability, and taste masking is explained. The recent advancement of CDs in developing various drug delivery systems is enlightened. Indeed, the potential of CDs by means of inclusion complex formation have widen the applicability of these materials in various drug delivery systems including ocular, osmotic, mucoadhesive, transdermal, nasal, and targeted delivery systems. Feasibility studies have been performed on the benefit of these cyclic oligomers as nanocarriers, a strategy that can modify the drugs with improved physicochemical properties. Studies also demonstrated the feasibility of CDs to self‐assemble in the form of stable nanoaggregates, which may extend the scope of CDs in drug delivery to the continually expanding list of new drug entities.
This paper references
10.1208/s12249-010-9541-6
Response Surface Methodology to Optimize Novel Fast Disintegrating Tablets Using β Cyclodextrin as Diluent
S. Late (2010)
Solid lipid nanoparticles with and without hydroxypropyl-β-cyclodextrin: A comparative study of nanoparticles designed for colonic drug
G. Spada (2012)
Pharmacodynamic and pharmacokinetic investigation of cyclodextrin-mediated asenapine maleate in situ nasal gel for improved bioavailability. Drug Development and Industrial Pharmacy
J A Kulkarni (2017)
10.1016/J.REACTFUNCTPOLYM.2016.08.008
Poly(lactide-co-glycolide)/cyclodextrin (polyethyleneimine) microspheres for controlled delivery of dexamethasone
Sanda Bucătariu (2016)
10.1016/j.colsurfb.2014.05.030
Itraconazole-hydroxypropyl-β-cyclodextrin loaded deformable liposomes: in vitro skin penetration studies and antifungal efficacy using Candida albicans as model.
Abdullah H. Alomrani (2014)
10.1016/J.EURPOLYMJ.2009.01.031
Preparation and characteristics of hydroxypropyl-β-cyclodextrin polymeric nanocapsules loading nimodipine
Yong-Zhong Du (2009)
10.1016/j.ijpharm.2013.10.005
A novel lactoferrin-modified β-cyclodextrin nanocarrier for brain-targeting drug delivery.
Y. Ye (2013)
10.1016/j.ijpharm.2011.04.031
Chitosan/sulfobutylether-β-cyclodextrin nanoparticles as a potential approach for ocular drug delivery.
Azza A. Mahmoud (2011)
10.1023/A:1023098730627
Mucoadhesive Sustained Drug Delivery System Based on Cationic Polymer and Anionic Cyclodextrin/Triclosan Complex
H. Sigurdsson (2002)
10.1088/0957-4484/23/9/095101
Solid lipid nanoparticles with and without hydroxypropyl-β-cyclodextrin: a comparative study of nanoparticles designed for colonic drug delivery.
G. Spada (2012)
10.4081/AMS.2011.E12
Gastro-retentive floating beads of curcumin β-cyclodextrin complex to treat stomach tumors
S. Goindi (2011)
10.1016/J.IJPHARM.2004.08.002
Applicability of (SBE)7m-β-CD in controlled-porosity osmotic pump tablets (OPTs)
K. Okimoto (2004)
10.1016/j.jconrel.2015.05.254
β-cyclodextrin based colon targeted delivery systems of aspirin: Synthesis, and in vitro assessment.
Peipei Ma (2015)
10.1088/0957-4484/19/18/185101
Novel drug nanocarriers combining hydrophilic cyclodextrins and chitosan.
A. Trapani (2008)
10.1111/j.1755-3768.2011.02299.x
Topical drug delivery to the eye: dorzolamide
T. Loftsson (2012)
Pharmacodynamic and pharmaco
J. A. Kulkarni (2017)
10.1016/j.ejpb.2015.05.019
Intranasal delivery of dopamine to the striatum using glycol chitosan/sulfobutylether-β-cyclodextrin based nanoparticles.
S. Di Gioia (2015)
10.1081/PDT-100100548
Development and Testing of an Improved Parenteral Formulation of Phenytoin Using 2-Hydroxypropyl-β-cyclodextrin
J. Blanchard (2000)
10.1080/13543776.2017.1384816
Cyclodextrins improving the physicochemical and pharmacological properties of antidepressant drugs: a patent review
T. C. Diniz (2018)
10.1038/sj.gt.3301527
Development of formulations that enhance physical stability of viral vectors for gene therapy
MA Croyle (2001)
10.1002/jps.21567
Release mechanisms of a sparingly water-soluble drug from controlled porosity-osmotic pump pellets using sulfobutylether-beta-cyclodextrin as both a solubilizing and osmotic agent.
S. Sotthivirat (2009)
10.3109/08982104.2013.788026
Novel tretinoin formulations: a drug-in-cyclodextrin-in-liposome approach
A. Ascenso (2013)
Cyclodextrins: application in different routes of drug administration.
S. Shimpi (2005)
10.1016/J.CARBPOL.2007.11.005
Novel thiolated carboxymethyl chitosan-g-β-cyclodextrin as mucoadhesive hydrophobic drug delivery carriers
M. Prabaharan (2008)
A nanoparticle formulation of disulfiram
Y. Shimomura (2015)
The effect of pH and trietha
G. Gladys (2003)
10.1016/j.ijpharm.2014.04.029
β-Cyclodextrin-dextran polymers for the solubilization of poorly soluble drugs.
M. D. di Cagno (2014)
10.1016/j.carbpol.2015.04.048
Liposomes incorporating cyclodextrin-drug inclusion complexes: Current state of knowledge.
R. Gharib (2015)
10.1021/mp3005963
Cyclodextrin-mediated enhancement of riboflavin solubility and corneal permeability.
P. J. Morrison (2013)
10.1016/j.jpba.2009.11.013
Preparation and solid-state characterization of bupivacaine hydrochloride cyclodextrin complexes aimed for buccal delivery.
M. Jug (2010)
Enhanced dissolution and skin permeation profiles of epalrestat with β-cyclodextrin derivatives using a cogrinding
K. Tomono (2017)
Liposomes incorporating cyclodextrin–drug inclu
L. Auezova (2015)
Host-guest kinetic interactions between HP-β-cyclodextrin and drugs
Z. Guo (2017)
Evaluation of cyclodex - trin solubilization of drugs
T. Loftsson (2005)
Preparation and evaluation of fast-disintegrating effervescent tablets of glibenclamide. Drug Development and Industrial Pharmacy
S Jacob (2009)
10.1002/CHIN.201127273
Cyclodextrin-Based Gene Delivery Systems
C. Mellet (2011)
10.1016/J.IJPHARM.2007.02.034
alpha-Cyclodextrin/oil beads: an innovative self-assembling system.
A. Bochot (2007)
Physical methods and experimental techniques for the determination of the stability constants. In P. Somasundaran (Ed.), Encyclopedia of surface and colloid science (3rd ed.)
E. Junquera (2015)
10.3389/fphar.2018.00091
Nanoliposome-Encapsulated Brinzolamide-hydropropyl-β-cyclodextrin Inclusion Complex: A Potential Therapeutic Ocular Drug-Delivery System
Fazhan Wang (2018)
10.1016/j.ijpharm.2017.07.044
Formulations and toxicologic in vivo studies of aqueous cyclosporin A eye drops with cyclodextrin nanoparticles.
S. Jóhannsdóttir (2017)
10.1016/S0378-5173(00)00365-3
Influence of cyclodextrin complexation on the in vitro permeation and skin metabolism of dexamethasone.
R. F. Lopez (2000)
10.1208/pt070238
Mucoadhesive, thermosensitive, prolonged-release vaginal gel for clotrimazole: β-cyclodextrin complex
E. Bilensoy (2008)
Cyclodextrins and their Derivatives in Drug Delivery: A Review
C. Palem (2012)
10.1080/03639045.2016.1236808
Pharmacodynamic and pharmacokinetic investigation of cyclodextrin-mediated asenapine maleate in situ nasal gel for improved bioavailability
J. A. Kulkarni (2017)
10.1016/J.FJPS.2016.08.001
Formulation of risperidone in floating microparticles to alleviate its extrapyramidal side effects
H. Ammar (2016)
10.1248/CPB.57.545
Preparation and evaluation of gastroretentive floating tablets of Silymarin.
R. Garg (2009)
10.1016/j.ijpharm.2017.06.029
Poly(ethylene oxide)/hydroxypropyl-β-cyclodextrin films for oromucosal delivery of hydrophilic drugs.
I. d'Angelo (2017)
10.1016/J.JCONREL.2007.07.018
The utility of cyclodextrins for enhancing oral bioavailability.
R. Carrier (2007)
10.1371/journal.pone.0109090
Thermosensitive and Mucoadhesive Sol-Gel Composites of Paclitaxel/Dimethyl-β-Cyclodextrin for Buccal Delivery
Soon Gil Choi (2014)
10.1080/10611860600834433
Drug delivery strategies for common orofacial diseases
X. Liu (2006)
10.1208/s12249-012-9877-1
Molecular Modeling-Based Inclusion Mechanism and Stability Studies of Doxycycline and Hydroxypropyl-β-Cyclodextrin Complex for Ophthalmic Delivery
Haohao Zhang (2012)
Preparation and evaluation
S. Jacob (2009)
Cyclodextrins: Application
S. Shimpi (2005)
10.2147/DDDT.S97982
Formulation, optimization, and pharmacodynamic evaluation of chitosan/phospholipid/β-cyclodextrin microspheres
Lu Shan (2016)
10.1016/j.ijpharm.2017.11.048
Liposomes encapsulating native and cyclodextrin enclosed paclitaxel: Enhanced loading efficiency and its pharmacokinetic evaluation.
Priyanka C. Bhatt (2018)
10.1002/EJOC.200700933
Amphiphilic Cyclodextrins – Advances in Synthesis and Supramolecular Chemistry
F. Sallas (2008)
Solid lipid nanoparticles: An effective lipid based technology for poorly water soluble drugs
S. Kamboj (2010)
10.1016/j.ijpharm.2015.04.044
Fast releasing oral electrospun PVP/CD nanofiber mats of taste-masked meloxicam.
W. Samprasit (2015)
10.1016/j.drudis.2015.11.017
Cyclodextrins in pharmaceutical formulations I: structure and physicochemical properties, formation of complexes, and types of complex.
Sunil S. Jambhekar (2016)
Influence of β - cyclodextrin complexation on lovastatin release from osmotic pump tablets (OPT)
A. Mehramizi (2007)
10.4155/tde-2017-0087
Cross-linked hyaluronan films loaded with acetazolamide-cyclodextrin-triethanolamine complexes for glaucoma treatment.
J. A. Calles (2018)
10.2174/1568026616666161222101104
Amphiphilic Cyclodextrin Derivatives for Targeted Drug Delivery to Tumors.
N. Erdoğar (2017)
Thiolated cyclodextrin: Development
A. Bernkop-Schnürch (2016)
Development and evaluation
A. P. Sherje (2018)
Formulation of indo
M. A. Halim Mohamed (2011)
10.1080/10837450701563277
In Vitro Controlled Release of Alfuzosin Hydrochloride Using HPMC-Based Matrix Tablets and Its Comparison with Marketed Product
Anroop B Nair (2007)
10.1016/j.ijpharm.2014.08.021
Hydroxypropyl-β-cyclodextrin grafted polyethyleneimine used as transdermal penetration enhancer of diclofenac sodium.
Yan Yan (2014)
10.1016/j.ejpb.2008.12.006
Modulation of release rate and barrier transport of Diclofenac incorporated in hydrophilic matrices: role of cyclodextrins and implications in oral drug delivery.
A. Miro (2009)
10.2174/1567201814666170419113933
Development of a Chitosan-based Nanoparticle Formulation for Ophthalmic Delivery of Honokiol.
F. Deng (2018)
10.1016/j.carbpol.2017.02.071
Hyaluronic acid and beta cyclodextrins films for the release of corneal epithelial cells and dexamethasone.
C. Fiorica (2017)
10.1208/s12249-016-0609-9
Improvement of the Ocular Bioavailability of Econazole Nitrate upon Complexation with Cyclodextrins
A. H. A. Abd El-Gawad (2016)
10.1016/j.carbpol.2012.12.033
β-Cyclodextrin hydrogels for the ocular release of antibacterial thiosemicarbazones.
R. Glisoni (2013)
10.1080/03639045.2018.1442844
In vitro and in vivo evaluation of cyclodextrin-based nanosponges for enhancing oral bioavailability of atorvastatin calcium
M. F. Zidan (2018)
10.1002/jps.23373
Transdermal iontophoretic delivery of propofol: a general anaesthetic in the form of its phosphate salt.
A. Juluri (2013)
PHASE-SOLUBILITY TECHNIQUES
T. Higuchi (1965)
10.1080/08982104.2016.1224897
Preparation and evaluation of niosome gel containing acyclovir for enhanced dermal deposition
Shery Jacob (2017)
10.1016/S0032-9592(03)00258-9
Cyclodextrins and their uses: a review
E. D. Valle (2004)
10.1166/JNN.2013.8091
Carboxymethyl dextran-cyclodextrin conjugate as the carrier of doxorubicin.
M. Sivasubramanian (2013)
10.1007/s13346-013-0140-4
Cyclodextrin-based targeting strategies for tumor treatment
J. Yin (2013)
10.3109/02713683.2010.536294
Formulation of Indomethacin Eye Drops via Complexation with Cyclodextrins
Maaly A Halim Mohamed (2011)
Topical drug delivery.
I. Squire (1992)
10.1211/jpp/61.04.0003
A study on the effect of inorganic salts in transungual drug delivery of terbinafine.
Anroop B Nair (2009)
Physical methods and experimental techniques for the determination of the stability constants
E. Junquera (2015)
10.1016/j.drudis.2015.11.016
Cyclodextrins in pharmaceutical formulations II: solubilization, binding constant, and complexation efficiency.
Sunil S. Jambhekar (2016)
10.1208/s12249-010-9411-2
Drug-Cyclodextrin-Vesicles Dual Carrier Approach for Skin Targeting of Anti-acne Agent
Navjot Kaur (2010)
10.1016/j.jconrel.2010.03.012
Increased oral bioavailability of paclitaxel by its encapsulation through complex formation with cyclodextrins in poly(anhydride) nanoparticles.
M. Agüeros (2010)
10.1016/j.exer.2015.01.022
A nanoparticle formulation of disulfiram prolongs corneal residence time of the drug and reduces intraocular pressure.
N. Nagai (2015)
10.1007/s10637-017-0461-0
New doxorubicin nanocarriers based on cyclodextrins
M. Viale (2017)
10.1002/JPS.10517
Inhibitory effect of sulfobutyl ether beta-cyclodextrin on DY-9760e-induced cellular damage: In vitro and in vivo studies.
Y. Nagase (2003)
10.3109/03639045.2016.1141932
Cyclodextrin–poloxamer aggregates as nanocarriers in eye drop formulations: dexamethasone and amphotericin B
P. Jansook (2016)
Preparation of solid drug/cyclodextrin complexes of acidic and basic drugs.
T. Loftsson (2004)
10.1016/j.ejps.2008.11.006
The stability and dissolution properties of solid glucagon/gamma-cyclodextrin powder.
L. Matilainen (2009)
10.1080/03639045.2018.1425426
Preparation and evaluation of carfentanil nasal spray employing cyclodextrin inclusion technology
Peng Yang (2018)
10.1016/j.carbpol.2018.01.011
Taste masking and rheology improvement of drug complexed with beta-cyclodextrin and hydroxypropyl-β-cyclodextrin by hot-melt extrusion.
Lorena F.B. Malaquias (2018)
Inhibitory effect of sulfobutyl ether β-cyclodextrin
Y. Nagase (2003)
Evaluation of cyclodex
T. Loftsson (2005)
10.1080/17425247.2017.1248398
Molecularly imprinted cyclodextrin nanosponges for the controlled delivery of L-DOPA: perspectives for the treatment of Parkinson’s disease
F. Trotta (2016)
10.1007/S10847-004-8841-9
Co-grinding with Cyclodextrin as a Nanoparticle Preparation Method of a Poorly Water Soluble Drug
Y. Tozuka (2004)
10.1016/j.ejps.2011.10.002
Albumin nanoparticles carrying cyclodextrins for nasal delivery of the anti-Alzheimer drug tacrine.
B. Luppi (2011)
10.1016/j.ijpharm.2009.12.039
5-Fluorouracil acetic acid/beta-cyclodextrin conjugates: drug release behavior in enzymatic and rat cecal media.
K. Udo (2010)
10.1208/s12249-016-0589-9
Potential Use of Cyclodextrin Complexes for Enhanced Stability, Anti-inflammatory Efficacy, and Ocular Bioavailability of Loteprednol Etabonate
O. A. Soliman (2016)
10.1021/MA020664O
New Supramolecular Assemblies of a Cyclodextrin-Grafted Chitosan through Specific Complexation
Rachel Auzély-Velty and (2002)
Self-assembling modified β-cyclodextrin nanoparticles
B. M. Godinho (2013)
10.1080/03639040802337021
Preparation and evaluation of fast-disintegrating effervescent tablets of glibenclamide.
Shery Jacob (2009)
10.1016/j.ejps.2009.02.010
Bioadhesive properties and biodistribution of cyclodextrin-poly(anhydride) nanoparticles.
M. Agüeros (2009)
10.1155/2014/127495
Evaluation of Skin Permeation and Analgesic Activity Effects of Carbopol Lornoxicam Topical Gels Containing Penetration Enhancer
S. Al-suwayeh (2014)
10.1023/A:1011033121528
Colonic Drug Delivery: Prodrug Approach
V. Sinha (2004)
10.1080/03639045.2017.1414232
A novel ion-activated in situ gelling ophthalmic delivery system based on κ-carrageenan for acyclovir
Pingfei Li (2018)
10.1016/J.EJPB.2007.06.004
Sustained-release matrix tablets of metformin hydrochloride in combination with triacetyl-beta-cyclodextrin.
G. Corti (2008)
10.1016/j.ejps.2017.05.047
Enhanced dissolution and skin permeation profiles of epalrestat with &bgr;‐cyclodextrin derivatives using a cogrinding method
T. Furuishi (2017)
Effect of hydroxypropyl-beta-cyclodextrin on the solubility, stability and in-vitro release of ciprofloxacin for ocular drug delivery.
A. Bozkır (2012)
Applicability of (SBE) 7m-β-CD
K. Okimoto (2004)
10.1016/J.IJPHARM.2006.02.006
Influence of modified cyclodextrins on solubility and percutaneous absorption of celecoxib through human skin.
C. A. Ventura (2006)
10.3762/bjnano.8.145
Development of polycationic amphiphilic cyclodextrin nanoparticles for anticancer drug delivery
Gamze Varan (2017)
10.1016/j.ijpharm.2016.01.024
Diclofenac-β-cyclodextrin for colonic drug targeting: In vivo performance in rats.
A. Vieira (2016)
10.1016/J.EJPS.2007.09.010
Development and pharmacological evaluation of ropivacaine-2-hydroxypropyl-beta-cyclodextrin inclusion complex.
D. R. de Araújo (2008)
10.1155/2014/487563
Connecting Soil Organic Carbon and Root Biomass with Land-Use and Vegetation in Temperate Grassland
D. McGranahan (2014)
10.3762/bjoc.11.22
Formulation development, stability and anticancer efficacy of core-shell cyclodextrin nanocapsules for oral chemotherapy with camptothecin
H. Ünal (2015)
10.1016/j.ejpb.2017.04.028
Cyclodextrin‐based nanosponges for the targeted delivery of the anti‐restenotic agent DB103: A novel opportunity for the local therapy of vessels wall subjected to percutaneous intervention
V. Coviello (2017)
10.1016/S0928-0987(03)00025-3
Multimodal molecular encapsulation of nicardipine hydrochloride by β-cyclodextrin, hydroxypropyl-β-cyclodextrin and triacetyl-β-cyclodextrin in solution. Structural studies by 1H NMR and ROESY experiments
C. Fernandes (2003)
Cyclodextrins as functional excipi
T. Loftsson (2012)
10.1155/2014/950358
Hydroxypropyl-β-cyclodextrin: A Novel Transungual Permeation Enhancer for Development of Topical Drug Delivery System for Onychomycosis
P. Chouhan (2014)
10.1201/9781439832387.ch4
Pharmaceutical applications.
P. Lee (1991)
10.1016/J.JFLUCHEM.2008.09.005
Sustained release applications of a fluoroalkyl ester-functionalized amphiphilic cyclodextrin by inclusion complex formation with water-soluble drugs in supercritical carbon dioxide
Hullathy Subban Ganapathy (2008)
10.7150/IJMS.7.232
Influence of Cyclodextrin Complexation with NSAIDs on NSAID/Cold Stress-Induced Gastric Ulceration in Rats
I. Alsarra (2010)
10.1007/s13346-012-0114-y
Transdermal delivery of cyclodextrin-solubilized curcumin
Raksha Ghanghoria (2012)
Sustained release
H. S. Ganapathy (2008)
Cyclodextrin complexes: Perspective from drug delivery and formulation
S Jacob (2018)
10.1080/10611860802556842
Mucoadhesive microspheres for nasal administration of cyclodextrins.
E. Gavini (2009)
10.1080/10837450.2016.1245319
Enhancement of levodopa stability when complexed with β-cyclodextrin in transdermal patches
R. Obaidat (2018)
10.1021/mp300188f
Folate-PEG-appended dendrimer conjugate with α-cyclodextrin as a novel cancer cell-selective siRNA delivery carrier.
Hidetoshi Arima (2012)
10.1111/jphp.12549
Development of cyclodextrin hydrogels for vaginal delivery of dehydroepiandrosterone
N. Mennini (2016)
10.1002/jps.22068
Development of mucoadhesive films for buccal administration of flufenamic acid: Effect of cyclodextrin complexation.
P. Mura (2010)
10.1208/s12249-010-9482-0
Parenteral Delivery of HPβCD: Effects on Drug-HSA Binding
Sergey V. Kurkov (2010)
10.1016/J.APSB.2012.05.004
Design of a gastroretentive mucoadhesive dosage form of furosemide for controlled release
Sharad Darandale (2012)
10.1111/j.2042-7158.2011.01279.x
Pharmaceutical applications of cyclodextrins: effects on drug permeation through biological membranes
T. Loftsson (2011)
10.1016/J.YRTPH.2004.05.008
Safety assessment of ?-cyclodextrin
I. Munro (2004)
10.1007/S10847-006-9259-Y
Thermosensitive mucoadhesive gel formulation loaded with 5-Fu: cyclodextrin complex for HPV-induced cervical cancer
E. Bilensoy (2007)
10.3390/molecules21121748
Cyclodextrins as Emerging Therapeutic Tools in the Treatment of Cholesterol-Associated Vascular and Neurodegenerative Diseases
Caroline Coisne (2016)
In vitro antiviral efficacy of the ganciclovir complexed with β-cyclodextrin on human
C. Nicolazzi (2002)
Preparation and evaluation of gastroreten
R. Garg (2009)
10.1016/j.xphs.2016.04.007
Brain-Targeting Chemical Delivery Systems and Their Cyclodextrin-Based Formulations in Light of the Contributions of Marcus E. Brewster.
P. Buchwald (2016)
10.1016/j.ijpharm.2014.08.066
Development of liposomal and microemulsion formulations for transdermal delivery of clonazepam: effect of randomly methylated β-cyclodextrin.
P. Mura (2014)
10.1016/j.ijpharm.2017.04.050
Cyclodextrin nanosystems in oral drug delivery: A mini review.
Oluwatomide Adeoye (2017)
10.1021/mp3003946
Self-assembling modified β-cyclodextrin nanoparticles as neuronal siRNA delivery vectors: focus on Huntington's disease.
B. Godinho (2013)
10.3109/10717544.2013.853213
Enhanced oral bioavailability of acyclovir by inclusion complex using hydroxypropyl-β-cyclodextrin
Anroop B Nair (2014)
10.1016/j.ijpharm.2017.07.016
Intracorneal melatonin delivery using 2-hydroxypropyl-β-cyclodextrin ophthalmic solution for granular corneal dystrophy type 2.
Jun-Hyun Ahn (2017)
10.1080/03639045.2017.1371732
Enhancement of oral bioavailability of anti-HIV drug rilpivirine HCl through nanosponge formulation*
Rana Zainuddin (2017)
10.1016/j.ijbiomac.2014.05.033
Bioadhesive tablets containing cyclodextrin complex of itraconazole for the treatment of vaginal candidiasis.
E. Cevher (2014)
10.1080/10611860802556842
Mucoadhesive microspheres for nasal administration of cyclodextrins
E. Gavini (2009)
10.1016/j.carbpol.2016.04.115
Preparation and evaluation of naringenin-loaded sulfobutylether-β-cyclodextrin/chitosan nanoparticles for ocular drug delivery.
P. Zhang (2016)
10.1023/A:1023082226992
Effect of 2-Hydroxypropyl-β-cyclodextrin on Release Rate of Metoprolol from Ternary Metoprolol/2-hydroxypropyl-β-cyclodextrin/Ethylcellulose Tablets
Yoichi Ikeda (2002)
10.1371/journal.pone.0150877
β-Cyclodextrin-Based Inclusion Complexation Bridged Biodegradable Self-Assembly Macromolecular Micelle for the Delivery of Paclitaxel
Yanzuo Chen (2016)
10.1016/j.ijpharm.2016.04.071
Cyclodextrin-based telmisartan ophthalmic suspension: Formulation development for water-insoluble drugs.
Chutimon Muankaew (2016)
10.1016/J.JCONREL.2003.10.002
Modulating drug release with cyclodextrins in hydroxypropyl methylcellulose gels and tablets.
B. Pose-Vilarnovo (2004)
10.1016/S0166-3542(01)00218-2
In vitro antiviral efficacy of the ganciclovir complexed with beta-cyclodextrin on human cytomegalovirus clinical strains.
C. Nicolazzi (2002)
10.1016/S0928-0987(03)00202-1
The effect of pH and triethanolamine on sulfisoxazole complexation with hydroxypropyl-β-cyclodextrin
G. Gladys (2003)
Drug delivery strategies
X. M. Liu (2006)
Mucoadhesive sustained
J. F. Sigurjonsdottir (2002)
Cyclodextrins
V. J. Stella (2008)
10.1016/J.EJPS.2003.10.029
Influence of hydroxypropyl-beta-cyclodextrin complexation on piroxicam release from buccoadhesive tablets.
M. Jug (2004)
Investigation of interaction of promethazine with cyclodextrins.
A. Lutka (2002)
10.1002/JPS.20831
Practical considerations in development of solid dosage forms that contain cyclodextrin.
Lee A Miller (2007)
10.1016/j.colsurfb.2015.10.045
Formulation and evaluation of nano based drug delivery system for the buccal delivery of acyclovir.
Bandar E Aldhubiab (2015)
10.1016/j.xphs.2016.03.009
Thiolated Cyclodextrin: Development of a Mucoadhesive Vaginal Delivery System for Acyclovir.
M. Ijaz (2016)
10.1016/j.jpba.2017.03.042
Host‐guest kinetic interactions between HP‐&bgr;‐cyclodextrin and drugs for prediction of bitter taste masking
Z. Guo (2017)
10.1016/j.xphs.2016.05.017
Neuroprotective Effects of Engineered Polymeric Nasal Microspheres Containing Hydroxypropyl-β-cyclodextrin on β-Amyloid (1-42)-Induced Toxicity.
A. Yalçin (2016)
10.1016/j.ijpharm.2010.04.006
Effective protection and controlled release of insulin by cationic beta-cyclodextrin polymers from alginate/chitosan nanoparticles.
N. Zhang (2010)
10.1039/B614899A
Per(6-guanidino-6-deoxy)cyclodextrins: synthesis, characterisation and binding behaviour toward selected small molecules and DNA.
Nikolaos Mourtzis (2007)
10.1080/09205063.2014.958016
In vitro drug release of natamycin from β-cyclodextrin and 2-hydroxypropyl-β-cyclodextrin-functionalized contact lens materials
Chau-Minh Phan (2014)
10.1208/s12249-017-0844-8
Development and Evaluation of pH-Responsive Cyclodextrin-Based in situ Gel of Paliperidone for Intranasal Delivery
A. Sherje (2017)
10.1002/jps.23077
Cyclodextrins as functional excipients: methods to enhance complexation efficiency.
T. Loftsson (2012)
10.1016/j.colsurfb.2013.04.045
Flurbiprofen PLGA-PEG nanospheres: role of hydroxy-β-cyclodextrin on ex vivo human skin permeation and in vivo topical anti-inflammatory efficacy.
E. Vega (2013)
10.1016/j.drudis.2015.05.008
Cyclodextrin nanoassemblies: a promising tool for drug delivery.
V. Bonnet (2015)
10.1089/jop.2013.0164
Dorzolamide cyclodextrin nanoparticle suspension eye drops and Trusopt in rabbit.
G. Jóhannesson (2014)
10.1016/J.IJPHARM.2005.05.042
Evaluation of cyclodextrin solubilization of drugs.
T. Loftsson (2005)
10.1016/j.colsurfb.2014.07.005
Folate-conjugated beta-cyclodextrin-based polymeric micelles with enhanced doxorubicin antitumor efficacy.
L. Zhang (2014)
10.1023/B:PHAM.0000032998.84488.7a
Cyclodextrins in Nasal Delivery of Low-Molecular-Weight Heparins: In Vivo and in Vitro Studies
T. Yang (2004)
Formulation, optimization, and pharmacodynamic evaluation of chitosan/phospholipid/β-cyclodextrin microspheres. Drug Design
L Shan (2016)
10.1016/J.IJPHARM.2005.12.046
Acrylic/cyclodextrin hydrogels with enhanced drug loading and sustained release capability.
Ulf Siemoneit (2006)
10.1016/j.ijpharm.2014.11.052
Gemcitabine and γ-cyclodextrin/docetaxel inclusion complex-loaded liposome for highly effective combinational therapy of osteosarcoma.
Liang Sun (2015)



This paper is referenced by
10.1016/j.carbpol.2020.116401
Cyclodextrin as a magic switch in covalent and non-covalent anticancer drug release systems.
Bingren Tian (2020)
10.1016/j.jddst.2020.101643
Engineered nanosponges as versatile biodegradable carriers: An insight
Ankit Jain (2020)
10.1016/j.ijpharm.2020.119149
Crystallization tendency of APIs possessing different thermal and glass related properties in amorphous solid dispersions.
Afroditi Kapourani (2020)
10.1208/s12249-019-1579-5
Orodispersible Carbamazepine/Hydroxypropyl-β-Cyclodextrin Tablets Obtained by Direct Compression with Five-in-One Co-processed Excipients
J. L. A. Conceição (2020)
10.1016/J.MOLLIQ.2019.03.092
Thermodynamic parameters for the complexation of water-soluble betulin derivatives with (2-hydroxypropyl)-β-cyclodextrin determined by affinity capillary electrophoresis
Viktoria V Sursyakova (2019)
10.1007/s00216-020-02777-4
Determination of binding constants for strong complexation by affinity capillary electrophoresis: the example of complexes of ester betulin derivatives with (2-hydroxypropyl)-γ-cyclodextrin
Viktoria V Sursyakova (2020)
10.3390/molecules25040998
Inclusion of the Phytoalexin trans-Resveratrol in Native Cyclodextrins: A Thermal, Spectroscopic, and X-Ray Structural Study
Laura Catenacci (2020)
10.1016/j.biomaterials.2019.119619
Metal-organic frameworks for stimuli-responsive drug delivery.
Ying Wang (2019)
10.3390/pharmaceutics12010055
Influence of Composition and Spray-Drying Process Parameters on Carrier-Free DPI Properties and Behaviors in the Lung: A review
Anna Lechanteur (2020)
10.2174/1389201020666190621104624
Encapsulation of venom-derived peptides and toxins for pharmaceutical application.
Ana Paula dos Santos (2019)
10.1080/17425247.2020.1730808
Nanocarriers: more than tour de force for thymoquinone
C. Rathore (2020)
10.3390/SCIPHARM87030015
Current approaches to use cyclodextrins and mucoadhesive polymers in ocular drug delivery-a mini-review
Tivadar Bíró (2019)
10.1007/s13346-020-00734-3
Improvement of oral bioavailability of carvedilol by liquisolid compact: optimization and pharmacokinetic study
Mimansa Jhaveri (2020)
10.1016/J.MOLLIQ.2019.111513
Physicochemical properties and fungicidal activity of inclusion complexes of fungicide chlorothalonil with β-cyclodextrin and hydroxypropyl-β-cyclodextrin
Shuang Gao (2019)
10.1007/s13346-020-00778-5
Cyclodextrin-based delivery systems for in vivo-tested anticancer therapies
A. Santos (2020)
10.1039/c9nj03293b
Fluorescence solvatochromism and modulated anticholinergic activity of novel coumarin compounds sequestered in human serum albumin nanocavities
Mostofa Ataur Rohman (2019)
10.1016/j.carbpol.2020.116448
Characterization of β-cyclodextrin/myrtenol complex and its protective effect against nociceptive behavior and cognitive impairment in a chronic musculoskeletal pain model.
L. Heimfarth (2020)
10.1186/s40824-020-0184-8
Emerging role of nanosuspensions in drug delivery systems
Shery Jacob (2020)
10.1002/AOC.4861
Ultrasound‐assisted green synthesis of Cu‐based complexes of β‐cyclodextrin and their SOD‐like activity
Behnaz Nikzad-kojanag (2019)
10.3390/ijms21176399
Rocuronium Has a Suppressive Effect on Platelet Function via the P2Y12 Receptor Pathway In Vitro That Is Not Reversed by Sugammadex
Y. Murata (2020)
Semantic Scholar Logo Some data provided by SemanticScholar